| Literature DB >> 35629087 |
Shin-Woong Ko1, Hyoung-Joon Chun1, Hyeong-Joong Yi1, Kyu-Sun Choi1.
Abstract
We evaluated the trend of admission of patients with acute cerebrovascular accidents (CVAs) during social distancing measures implemented during the coronavirus disease 2019 (COVID-19) era. The data of patients admitted with transient ischemic attack, ischemic stroke, intracerebral hemorrhage (ICH), and subarachnoid hemorrhage (SAH) to the emergency department of the Hanyang University Seoul Hospital were retrospectively analyzed. The data were compared between the pre-COVID-19 and COVID-19 periods. Poisson regression analysis was performed to evaluate changes in admission rates as a function of the year, social distancing level, and the interaction between the year and social distancing level. The number of admissions for CVAs dropped from 674 in the pre-COVID-19 period to 582 in the COVID-19 period. The decline in the number of admissions for ICH during social distancing measures was statistically significant, while the declines in SAH and ischemic stroke admissions were not. When the social distancing level was raised, admissions for CVAs dropped by 19.8%. The correlation between social distancing and decreased admissions for CVAs is a paradoxical relationship that may be of interest to the field of public health.Entities:
Keywords: COVID-19; cerebrovascular accident; intracerebral hemorrhage; ischemic stroke; social distancing; subarachnoid hemorrhage; transient ischemic attack
Year: 2022 PMID: 35629087 PMCID: PMC9146697 DOI: 10.3390/jpm12050664
Source DB: PubMed Journal: J Pers Med ISSN: 2075-4426
Key points of the revised social distancing plan [15].
| Classification | Level 1 | Level 2 | Level 3 | Level 4 |
|---|---|---|---|---|
| Definition | Contained and stable | Local transmission/cap on gathering size | Regional transmission/ban on gatherings | Full-blown nationwide transmission/ban on going out |
| Decision/ | CDSCH | |||
| Criteria | <1 case/100,000 people (weekly average) | ≥1 case/100,000 people (weekly average > threshold for 3+ days) | ≥2 cases/100,000 people (weekly average > threshold for 3+ days) | ≥4 cases/100,000 people (weekly average > threshold for 3+ days) |
| Private gatherings | Comply with COVID-19 protocols | Up to 8 people | Up to 4 people | Up to 2 people after 18:00 |
| Fully/partially vaccinated people are not counted for immediate family gatherings | ||||
| Events | 500+ people only with advance reporting to local authorities | 100+ people prohibited | 50+ people prohibited | Events prohibited |
| Fully vaccinated people are not counted for events | ||||
| Assemblies | 500+ people prohibited | 100+ people prohibited | 50+ people prohibited | Prohibited except for 1-person protests |
| Fully vaccinated people are not counted for assemblies | ||||
* Si/gun/gu, administrative divisions of South Korea; CDSCH, Central Disaster and Safety Countermeasures Headquarters.
Characteristics of patients admitted for cerebrovascular accidents in 2019 and 2020.
| 2019 ( | 2020 ( | ||
|---|---|---|---|
| Age, mean ± SD *, y | 65.38(14.72) | 65.18(15.09) | 0.821 |
| Women, | 316 (0.47) | 265 (0.46) | 0.6728 |
| Hypertension, | 376 (0.56) | 325 (0.56) | 1 |
| Hyperlipidemia, | 207 (0.31) | 194 (0.33) | 0.3508 |
| Diabetes mellitus, | 173 (0.26) | 138 (0.24) | 0.4621 |
| Heart failure, | 23 (0.03) | 8 (0.01) | 0.02345 |
| Arrythmia, | 72 (0.11) | 42 (0.07) | 0.04198 |
| Chronic renal failure, | 30 (0.04) | 28 (0.05) | 0.8663 |
| Antiplatelet agent usage, | 145 (0.22) | 130 (0.22) | 0.7768 |
| Anticoagulant usage, | 27 (0.04) | 25 (0.04) | 0.9085 |
| Smokers, | 261 (0.39) | 224 (0.38) | 0.978 |
| Mean monthly admissions, mean ± SD *, | 56.17 (7.65) | 48.5 (9.68) | 0.06018 |
* SD, standard deviation.
Figure 1Comparison of admissions for cerebrovascular accidents between 2019 and 2020. TIA, transient ischemic attack.
Characteristics of patients admitted for ICH, ischemic stroke and SAH in 2019 and 2020.
| Disease | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Intracerebral Hemorrhage | Ischemic Stroke | Subarachnoid Hemorrhage | |||||||
| 2019 | 2020 ( | 2019 | 2020 | 2019 | 2020 ( | ||||
| Age, mean ± SD *, y | 61.52 (15.97) | 61.55 (14.2) | 0.9853 | 69.04 (13.1) | 68.43 (14.57) | 0.5542 | 58.54 (14.22) | 58.06 (14.49) | 0.8067 |
| Female, | 71 (41%) | 42 (38%) | 0.6363 | 178 (46%) | 147 (41%) | 0.1873 | 67 (60%) | 76 (70%) | 0.1574 |
| Hypertension, | 85 (0.49) | 66 (0.59) | 0.1345 | 244 (0.63) | 221 (0.61) | 0.7248 | 47 (0.42) | 38 (0.35) | 0.3432 |
| Hyperlipidemia, | 32 (0.18) | 28 (0.25) | 0.2434 | 156 (0.40 | 145 (0.40) | 1 | 19 (0.17) | 21 (0.19) | 0.7866 |
| Diabetes mellitus, | 34 (0.20) | 17 (0.15) | 0.4212 | 126 (0.32) | 110 (0.30) | 0.6252 | 13 (0.12) | 11 (0.10) | 0.8845 |
| Heart failure, | 4 | 0 | - | 19 (0.049) | 8 (0.02) | 0.0777 | 0 | 0 | - |
| Arrythmia, | 13 (0.08) | 3 (0.03) | 0.1419 | 57 (0.15) | 39 (0.11) | 0.1421 | 2 (0.02) | 0 | 0.4896 |
| Chronic renal failure, | 9 (0.05) | 6 (0.05) | 1 | 18 (0.05) | 21 (0.06) | 0.57 | 3 (0.03) | 1 (0.01) | 0.6333 |
| Antiplatelet agent usage, | 30(0.17) | 20 (0.18) | 1 | 109 (0.28) | 100 (0.28) | 0.9858 | 6 (0.05) | 10 (0.09) | 0.4032 |
| Anticoagulant usage, | 6 (0.03) | 3 (0.03) | 0.9796 | 19 (0.05) | 20 (0.06) | 0.8111 | 2 (0.02) | 2 (0.02) | 1 |
| Smokers, | 68 (0.39) | 35 (0.31) | 0.2089 | 152 (0.39) | 153 (0.42) | 0.3987 | 41 (0.37) | 36 (0.33) | 0.6768 |
| Mean monthly admissions, | 14.4 (3.42) | 9.3 (4.33) | 0.001079 | 32.5 (4.70) | 30.2 (7.66) | 0.3873 | 9.3 (4.22) | 9.0 (2.86) | 0.8853 |
* SD, standard deviation.
Poisson regression analysis of seasonal variation and year-by-year interactions in patients with cerebrovascular accidents.
| Estimate | Exp * | Standard Error | z Value | Pr (>|z|) | |
|---|---|---|---|---|---|
| Year 2020 | −0.14676 | 0.86350 | 0.056585 | −2.594 | 0.0095 |
| Summer | −0.049393 | 0.9518 | 0.078591 | −0.628 | 0.5297 |
| Fall | −0.173923 | 0.84036 | 0.081217 | −2.141 | 0.0322 |
| Winter | −0.009077 | 0.99096 | 0.077792 | −0.117 | 0.9071 |
* Exp, exponential value.
Figure 2Relationship between COVID-19 and admissions for CVA. (a) Monthly numbers of patients with COVID-19 in Seoul, South Korea; (b) comparison of monthly numbers of patients admitted for CVA between 2019 and 2020 (cases of traumatic brain injury were excluded); (c) comparison of monthly variations in numbers of patients with CVA between 2019 and 2020. COVID-19, coronavirus disease 2019; CVA, cerebrovascular accident.
Poisson regression analysis of seasonal variation and year-by-year interactions in patients with intracerebral hemorrhage.
| Estimate | Exp * | Standard Error | z Value | Pr (>|z|) | |
|---|---|---|---|---|---|
| Year 2020 | −0.4348 | 0.64739 | 0.1213 | −3.585 | 0.000337 |
| Summer | −0.1411 | 0.8684 | 0.1683 | −0.838 | 0.401758 |
| Fall | −0.4389 | 0.64475 | 0.1832 | −2.396 | 0.01659 |
| Winter | 0.2126 | 1.23689 | 0.1543 | 1.378 | 0.168221 |
* Exp, exponential value.
Figure 3Relationship between COVID-19 and admissions for ICH. (a) Monthly numbers of patients with COVID-19 in Seoul, South Korea; (b) comparison of monthly admissions for spontaneous ICH between 2019 and 2020; (c) comparison of monthly variations in numbers of patients with ICH between 2019 and 2020. COVID-19, coronavirus disease 2019; ICH, intracerebral hemorrhage.
Figure 4(a) Monthly numbers of patients with COVID-19 in Seoul, South Korea; (b) comparison of monthly admissions for SAH between 2019 and 2020; (c) comparison of monthly variations in numbers of patients with SAH between 2019 and 2020. COVID-19, coronavirus disease 2019; SAH, subarachnoid hemorrhage.
Figure 5(a) Monthly numbers of patients with COVID-19 in Seoul, South Korea; (b) comparison of monthly admissions for ischemic stroke between 2019 and 2020; (c) comparison of monthly variations in numbers of patients with ischemic stroke between 2019 and 2020. COVID-19, coronavirus disease 2019.
Poisson regression analysis of seasonal variation and year-by-strength interactions in 2020.
| Estimate | Exp † | Standard Error | z Value | Pr (>|z|) | |
|---|---|---|---|---|---|
| Summer | −0.04039 | 0.9604148 | 0.11899 | −0.339 | 0.73432 |
| Fall | −0.24955 | 0.7791513 | 0.13167 | −1.895 | 0.05806 |
| Winter | −0.31829 | 0.7273918 | 0.11649 | −2.732 | 0.00629 |
| Strength * | −0.22031 | 0.8022701 | 0.09785 | −2.252 | 0.02435 |
* Combination of strengths 1, 2, and 3; Exp, exponential value.
Poisson regression analysis for each strength period in 2020.
| Estimate | Exp | Standard Error | z Value | Pr (>|z|) | |
|---|---|---|---|---|---|
| Strength 1 | −0.41838 | 0.6581121 | 0.13106 | −3.192 | 0.001411 |
| Strength 2 | 0.01326 | 1.013348 | 0.14742 | 0.09 | 0.928324 |
| Strength 3 | −0.08163 | 0.9216129 | 0.15735 | −0.519 | 0.603934 |
Strength 1: 18 February to 5 May, strength 2: 12 August to 12 November, strength 3: 13 November onward.